Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:AFMD’

Michael Castor of Sio Capital

Affimed NV (AFMD): Are Hedge Funds Right About This Stock?

World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients’ money after undertaking a rigorous examination......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Does Affimed NV (AFMD) Stack Up Against Its Peers?

The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors......(read more)
Samuel Isaly Orbimed Advisors

Affimed N.V. (AFMD): OrbiMed Advisors Cuts Its Position

A freshly-amended 13D filing with the US SEC showed that Sam Isaly’s OrbiMed Advisors has sold some of its shares of Affimed N.V. (NASDAQ:AFMD), hence......(read more)
Samuel Isaly Orbimed Advisors

Affimed NV (AFMD): Samuel Isaly Unloads Shares of Sinking Stock

Affimed NV (NASDAQ:AFMD) is the subject of a 13D filing from Samuel Isaly‘s OrbiMed Advisors, which shows that the investment firm has sold off......(read more)
stocks, analysis, market, numbers, business, ticket, trade, money, price

Why These 5 Stocks Are Surging Amid Today’s Gloomy Market

U.S stocks are heading south today, with oil prices putting pressure on the markets again. Major indices are down by more than 0.6% as the price of crude......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

What Does Hedge Fund Sentiment Say About Affimed NV (AFMD)?

The third quarter was a rough one for most investors, as fears of an interest rate hike in the U.S, a weakening economy in China, and a stagnant Europe......(read more)
Christian Leone Luxor Capital

Altisource Asset Management Corp (AAMC), Affimed Therapeutics BV (AFMD): Orbimed Advisors and Luxor Capital Group Are Bullish on These Companies

Altisource Asset Management Corp (NYSEMKT:AAMC) and Affimed Therapeutics BV (NASDAQ:AFMD) felt hedge funds’ bullishness lately. Samuel Isaly’s Orbimed......(read more)